Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study

CİNİSLİOĞLU, AHMET EMRE; UTLU, ADEM; AKSAKALLI, TUGAY; AKKAŞ, FATİH; ÖZMEN, KADİR; GEDİK, AHMET; Araz, Ömer; Yılmazel Uçar, Elif; Adanur, Şenol

doi:10.62425/rtpharma.1573724

Makale Tam Makale Ulusal 2024

Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study

AHMET EMRE CİNİSLİOĞLU, ADEM UTLU, TUGAY AKSAKALLI, FATİH AKKAŞ, KADİR ÖZMEN, AHMET GEDİK, Ömer Araz, Elif Yılmazel Uçar, Şenol Adanur

Recent Trends in Pharmacology 01.12.2024

DOI ile aç

Atıf için künye

CİNİSLİOĞLU, A. E., UTLU, A., AKSAKALLI, T., AKKAŞ, F., ÖZMEN, K., GEDİK, A., Araz, Ö., Yılmazel Uçar, E., & Adanur, Ş. (2024). Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study. Recent Trends in Pharmacology. https://doi.org/10.62425/rtpharma.1573724

BibTeX

@article{cinislioglu2024-220427,
  author = {CİNİSLİOĞLU, AHMET EMRE and UTLU, ADEM and AKSAKALLI, TUGAY and AKKAŞ, FATİH and ÖZMEN, KADİR and GEDİK, AHMET and Araz, Ömer and Yılmazel Uçar, Elif and Adanur, Şenol},
  title = {Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study},
  journal = {Recent Trends in Pharmacology},
  year = {2024},
  issn = {2980-194X},
  doi = {10.62425/rtpharma.1573724},
  url = {https://akademik.atauni.edu.tr/yayinlar/220427-does-mirabegron-the-v3-agonist-frequently-used-in-the-treatment-of-overactive}
}